Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Peers: DIS CMCSA FOXA NWS CHTR NWSA SBGI AMCX NXST EVC

| Held by: AVEM AVEE AVXC GOLS AVSE APIE

Index	-	P/E	-	EPS (ttm)	-1.25	Insider Own	0.25%	Shs Outstand	436.92M	Perf Week	1.25%
Market Cap	1.42B	Forward P/E	28.83	EPS next Y	0.11	Insider Trans	0.00%	Shs Float	435.83M	Perf Month	9.43%
Enterprise Value	4.96B	PEG	-	EPS next Q	-0.00	Inst Own	34.95%	Short Float	0.22%	Perf Quarter	8.33%
Income	-553.35M	P/S	0.47	EPS this Y	89.62%	Inst Trans	-48.51%	Short Ratio	0.67	Perf Half Y	31.58%
Sales	3.03B	P/B	0.31	EPS next Y	236.76%	ROA	-4.24%	Short Interest	0.98M	Perf YTD	11.68%
Book/sh	10.40	P/C	0.69	EPS next 5Y	-	ROE	-9.77%	52W High	3.47 -6.47%	Perf Year	49.77%
Cash/sh	4.73	P/FCF	4.65	EPS past 3/5Y	- -	ROIC	-5.38%	52W Low	1.55 109.68%	Perf 3Y	-36.51%
Dividend Est.	0.10 (3.07%)	EV/EBITDA	4.48	Sales past 3/5Y	-2.31% -8.46%	Gross Margin	36.63%	Volatility	3.97% 4.00%	Perf 5Y	-56.16%
Dividend TTM	0.09 (2.80%)	EV/Sales	1.64	EPS Y/Y TTM	-42.50%	Oper. Margin	5.10%	ATR (14)	0.13	Perf 10Y	-85.18%
Dividend Ex-Date	May 30, 2025	Quick Ratio	2.29	Sales Y/Y TTM	-18.32%	Profit Margin	-18.26%	RSI (14)	55.04	Recom	2.36
Dividend Gr. 3/5Y	0.00% -	Current Ratio	2.31	EPS Q/Q	-396.38%	SMA20	-0.29%	Beta	1.97	Target Price	4.38
Payout	-	Debt/Eq	0.92	Sales Q/Q	-3.27%	SMA50	5.77%	Rel Volume	1.92	Prev Close	3.31
Employees	28038	LT Debt/Eq	0.85	Earnings	Oct 23 AMC	SMA200	25.51%	Avg Volume	1.46M	Price	3.25
IPO	Dec 14, 1993	Option/Short	Yes / Yes	EPS/Sales Surpr.	-1487.86% 0.94%	Trades		Volume	2,760,428	Change	-1.81%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-27-25	Upgrade	JP Morgan	Neutral → Overweight
Aug-08-25	Downgrade	Goldman	Buy → Neutral	$2.60
Nov-14-24	Downgrade	JP Morgan	Overweight → Neutral
Apr-15-24	Downgrade	BofA Securities	Buy → Neutral
Jan-05-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Oct-05-23	Upgrade	BofA Securities	Neutral → Buy	$5 → $4.70
May-31-23	Initiated	Goldman	Buy	$6.10
Apr-19-23	Downgrade	UBS	Buy → Neutral	$8.80 → $6
Nov-29-22	Downgrade	BofA Securities	Buy → Neutral	$6.50
Aug-11-22	Downgrade	Credit Suisse	Outperform → Neutral	$8
Jun-28-22	Initiated	UBS	Buy	$13
Jun-02-22	Resumed	Goldman	Neutral	$11.50
Mar-23-22	Upgrade	Barclays	Underweight → Equal Weight	$11 → $13
Feb-04-22	Upgrade	BofA Securities	Neutral → Buy
Jun-24-21	Initiated	The Benchmark Company	Buy	$19
Dec-15-20	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Nov-11-19	Downgrade	Barclays	Equal Weight → Underweight
Feb-01-19	Upgrade	Citigroup	Neutral → Buy
Apr-03-18	Initiated	Goldman	Neutral	$18
Dec-15-17	Upgrade	JP Morgan	Neutral → Overweight

Show Previous Ratings

Feb-13-26 07:13AM	Is Grupo Televisa, S.A.B. (TV) One of Goldman Sachs Top Penny Stock Picks? (Insider Monkey)
Feb-03-26 10:26PM	Grupo Televisa, S.A.B. (TV): A Bull Case Theory (Insider Monkey)
Jan-28-26 09:37AM	Analyst Report: Grupo Televisa, S.A.B. (Morningstar Research)
Jan-07-26 07:02AM	Televisa Executives Buy $106 Million in Shares as Ownership Structure Shifts (GuruFocus.com)
Dec-31-25 11:41AM	Grupo Televisa (TV) Shows Stronger Cash Generation but Faces Growth Headwinds and Credit Downgrade (Insider Monkey)
11:15AM	Loading…
Dec-28-25 11:15AM	Grupo Televisa (TV) Sees Upside From TelevisaUnivision and YouTube TV Deal (Insider Monkey)
Nov-26-25 11:25AM	YouTube, TelevisaUnivision Reach Deal (The Wall Street Journal)
Nov-24-25 09:47AM	Televisa (TV) Posts Q3 Loss as Sky Segment Declines; Price Target Lifted to $3 (Insider Monkey)
Oct-29-25 08:50AM	Why Fast-paced Mover Grupo Televisa (TV) Is a Great Choice for Value Investors (Zacks)
Oct-27-25 08:52AM	Analyst Report: Grupo Televisa, S.A.B. (Morningstar Research) +5.44%
Oct-24-25 05:02PM	Grupo Televisa SAB (TV) Q3 2025 Earnings Call Highlights: Strategic Moves and Financial Performance (GuruFocus.com)
Oct-23-25 09:18AM	Grupo Televisa SAB (MEX:TLEVISACPO) Q3 2025 Earnings Report Preview: What To Look For (GuruFocus.com)
Oct-22-25 09:20AM	Grupo Televisa SAB (MEX:TLEVISACPO) Q3 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Oct-02-25 07:54PM	Analyst Report: Grupo Televisa, S.A.B. (Morningstar Research)
Sep-11-25 04:54AM	Strength Seen in Lumen (LUMN): Can Its 9.1% Jump Turn into More Strength? (Zacks)
07:44PM	Loading…
Aug-28-25 07:44PM	Analyst Report: Grupo Televisa, S.A.B. (Morningstar Research)
Aug-27-25 05:58AM	Grupo Televisa, S.A.B. (TV) Holds Steady in Analyst Ratings (Insider Monkey) +8.91%
Aug-13-25 03:38PM	Benchmark Raises Grupo Televisa (TV) Price Target on Q2 Cost Improvements (Insider Monkey)
Aug-05-25 07:55PM	Analyst Report: Grupo Televisa, S.A.B. (Morningstar Research)
Jul-31-25 09:40AM	Is Telecom Italia (TIIAY) Stock Outpacing Its Utilities Peers This Year? (Zacks)
Jul-30-25 05:28AM	Best Growth Stocks to Buy for July 30th (Zacks) +12.40%
Jul-24-25 02:49PM	Analyst Report: Grupo Televisa, S.A.B. (Morningstar Research)
Jul-23-25 12:00PM	All You Need to Know About Grupo Televisa (TV) Rating Upgrade to Strong Buy (Zacks)
Jun-30-25 08:50AM	Fast-paced Momentum Stock Grupo Televisa (TV) Is Still Trading at a Bargain (Zacks)
Jun-27-25 09:55AM	Grupo Televisa (TV)'s Technical Outlook is Bright After Key Golden Cross (Zacks)
Jun-13-25 09:40AM	Are Utilities Stocks Lagging National Grid Transco (NGG) This Year? (Zacks)
Jun-05-25 08:50AM	Why Fast-paced Mover Grupo Televisa (TV) Is a Great Choice for Value Investors (Zacks)
Jun-04-25 12:00PM	Grupo Televisa (TV) Upgraded to Buy: Here's Why (Zacks)
May-01-25 12:45PM	Analyst Report: Grupo Televisa, S.A.B. (Morningstar Research)
Apr-30-25 07:59PM	Grupo Televisa, S.A.B. (TV) Q1 2025 Earnings Call Transcript (Seeking Alpha)
09:17AM	Loading…
09:17AM	Grupo Televisa: Q1 Earnings Snapshot (Associated Press Finance)
Apr-29-25 04:49PM	Mexican broadcaster Televisa posts 66% profit slide in first quarter (Reuters) -5.50%
Apr-28-25 07:00PM	Grupo Televisa SAB (MEX:TLEVISACPO) Q1 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Mar-21-25 09:47AM	Grupo Televisa: A Great Test Of Patience (SeekingAlpha)
Mar-11-25 08:50AM	Despite Fast-paced Momentum, Grupo Televisa (TV) Is Still a Bargain Stock (Zacks)
Mar-08-25 10:14PM	Grupo Televisa, S.A.B. (TV): Among the Best NYSE Penny Stocks to Buy According to Analysts (Insider Monkey)
Feb-24-25 03:09PM	Analyst Report: Grupo Televisa, S.A.B. (Morningstar Research)
Feb-22-25 02:06AM	Grupo Televisa SAB (TV) Q4 2024 Earnings Call Highlights: Navigating Revenue Declines with ... (GuruFocus.com)
Feb-21-25 11:26AM	Grupo Televisa SAB (MEX:TLEVISACPO) Q4 2024 Earnings Report Preview: What to Expect (GuruFocus.com) -6.28%
Feb-20-25 05:52PM	Grupo Televisa: Q4 Earnings Snapshot (Associated Press Finance)
08:50AM	Grupo Televisa SAB (MEX:TLEVISACPO) Q4 2024 Earnings Report Preview: What to Expect (GuruFocus.com)
Oct-30-24 04:24PM	Billionaire David Martinez Acquires Stake in Mexicos Televisa (Bloomberg)
Oct-26-24 11:00AM	Grupo Televisa SAB (TV) Q3 2024 Earnings Call Highlights: Profitability Gains Amid Revenue ... (GuruFocus.com)
06:31AM	Grupo Televisa Faces Revenue Drop But Boosts Net Income (TipRanks)
Oct-25-24 04:55PM	Analyst Report: Grupo Televisa, S.A.B. (Morningstar Research) -9.75%
03:24PM	Azcárraga steps down as Televisa chief executive amid US soccer investigation (Associated Press Finance)
12:32PM	Televisa Chairman Azcarraga Resigns Amid FIFA Bribery Probe (Bloomberg)
05:39AM	Grupo Televisa: Q3 Earnings Snapshot (Associated Press Finance)
Oct-24-24 08:22PM	Televisa Chairman Takes Leave Pending DOJ International Soccer Probe (The Wall Street Journal)
05:25PM	Televisa chairman taking leave amid FIFA bribery probe (Reuters)
Oct-09-24 03:10PM	Grupo Televisa SAB (TV) Q2 2024 Earnings Call Highlights: Strong Cable Growth Amidst Revenue ... (GuruFocus.com)
Jul-25-24 01:48AM	Analyst Report: Grupo Televisa, S.A.B. (Morningstar Research)
Jul-23-24 06:31PM	Grupo Televisa: Q2 Earnings Snapshot (Associated Press Finance)
Jun-13-24 05:35PM	Gabelli Funds Commentary: GAMCO All Cap Value Fund Commmentary for May 2024 (GuruFocus.com)
May-09-24 06:37PM	25 Largest Companies in Mexico by Revenue (Insider Monkey)
Apr-30-24 10:28AM	Grupo Televisa, S.A.B. (NYSE:TV) Q1 2024 Earnings Call Transcript (Insider Monkey) -7.59%
Apr-29-24 10:24AM	Analyst Report: Grupo Televisa, S.A.B. (Morningstar Research)
Apr-26-24 04:33PM	EMERGING MARKETS-Latam stocks, FX track global markets higher, head for weekly gains (Reuters) +6.04%
12:20PM	Televisa to merge its satellite TV, cable units 'as soon as possible' (Reuters)
12:16PM	UPDATE 2-Televisa to merge its satellite TV, cable units 'as soon as possible' (Reuters)
11:15AM	Televisa to merge Sky, cable 'as soon as possible' (Reuters)
Apr-25-24 09:52PM	TV Stock Earnings: Grupo Televisa Beats EPS, Misses Revenue for Q1 2024 (InvestorPlace)
06:38PM	Grupo Televisa: Q1 Earnings Snapshot (Associated Press Finance)
04:45PM	UPDATE 2-Mexico's Televisa swings to $58 mln profit, but revenue underperforms (Reuters)
04:13PM	Mexico's Televisa swings to profit in Q1 (Reuters)
Apr-09-24 10:12PM	Mexican broadcaster Televisa inks financing deals worth over $1 bln (Reuters)
Apr-04-24 11:24AM	Mexicos Televisa to Buy Remaining Sky Stake From AT&T (Bloomberg)
Apr-03-24 06:31PM	Mexican broadcaster Televisa buys out AT&T's stake in Sky Mexico (Reuters) +5.40%
04:10PM	Broadcaster Televisa buys out AT&T for control of Sky satellite TV service (Reuters)
Mar-15-24 09:59PM	UPDATE 1-Moody's downgrades Mexican broadcaster Televisa's rating to Baa3 (Reuters)
07:40PM	Moody's downgrades Mexican broadcaster Televisa's rating to Baa3 (Reuters)
Mar-05-24 07:51AM	TV Stock Earnings: Grupo Televisa Reported Results for Q4 2023 (InvestorPlace)
Feb-26-24 11:29AM	Analyst Report: Grupo Televisa, S.A.B. (Morningstar Research)
Feb-24-24 08:54AM	Grupo Televisa, S.A.B. (NYSE:TV) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-23-24 11:56AM	12 Best Rising Penny Stocks To Buy (Insider Monkey)
11:09AM	UPDATE 2-Mexico's Televisa says brunt of $790 million capex for cable, Acapulco (Reuters)
10:31AM	Gruopo Televisa says 2024 CAPEX seen at $790 million (Reuters)
Feb-22-24 06:52PM	Grupo Televisa: Q4 Earnings Snapshot (Associated Press Finance)
05:44PM	UPDATE 2-Mexico's Televisa trims net loss in Q4, SKY lags (Reuters)
05:26PM	Mexico's Televisa trims net loss in Q4, SKY lags (Reuters)
05:17PM	Mexico's Televisa posts net loss in Q4 (Reuters)
Feb-20-24 07:11PM	Televisa Soccer, Gambling Spinoff Nearly Triples in Debut (Bloomberg)
Feb-19-24 08:31PM	Soccer-Mexico's America, Azteca Stadium set for stock market listing ahead 2026 World Cup (Reuters)
Jan-25-24 05:19PM	Mexico's Televisa close to launching sports and gaming spin-off (Reuters) +8.16%
Oct-29-23 07:06PM	Analyst Report: Grupo Televisa, S.A.B. (Morningstar Research)
01:30PM	Grupo Televisa, S.A.B. (NYSE:TV) Q3 2023 Earnings Call Transcript (Insider Monkey)
Oct-27-23 11:41AM	Televisa's battered shares seesaw after third quarter lands in red (Reuters)
11:29AM	EMERGING MARKETS-Latam FX, stocks advance after US inflation data; investors assess earnings (Reuters)
Oct-26-23 05:21PM	UPDATE 3-Mexico's Televisa swings to net loss in third quarter (Reuters)
04:55PM	Mexico's Televisa swings to net loss in third quarter (Reuters)
Oct-06-23 06:29PM	Analyst Report: Grupo Televisa, S.A.B. (Morningstar Research)
Sep-25-23 01:07PM	Grupo Televisa SAB (TV): A Deep Dive into Its Performance Metrics (GuruFocus.com) -5.57%
11:50AM	Grupo Televisa SAB (TV): A Hidden Value Trap? Unpacking the Risks and Rewards (GuruFocus.com)
Sep-15-23 12:08PM	Grupo Televisa SAB (TV): A Deep Dive into Its Performance Metrics (GuruFocus.com)
Sep-06-23 12:10PM	Grupo Televisa SAB (TV): A Deep Dive into Its Performance Metrics (GuruFocus.com)
Aug-28-23 06:30PM	12 Best High Risk Penny Stocks to Buy Now (Insider Monkey)
Jul-26-23 03:04PM	Analyst Report: Grupo Televisa, S.A.B. (Morningstar Research)
Jul-25-23 09:15PM	Mexico's Televisa posts big Q2 miss on Univision JV drop, satellite disconnections (Reuters)
07:15PM	UPDATE 2-Mexico's Televisa posts big Q2 miss on Univision JV drop, satellite disconnections (Reuters)
06:39PM	Mexico's Televisa posts 95% profit slide in second quarter (Reuters)

Grupo Televisa SAB is a telecommunications corporation which owns and operates one of the cable companies as well as a direct-to-home satellite pay television system. The firm offers integrated services, including video, high-speed data and voice to residential and commercial customers. It operates through the following segments: Cable, Sky, and Other Businesses. The Cable segment includes the operation of cable multiple systems covering the Mexico City metropolitan area. The Sky segment includes DTH broadcast satellite pay television services. The Other Businesses segment comprises of publishing, gaming, soccer, radio, feature-film distribution, and publishing distribution activities. The company was founded in 1930 and is headquartered in Mexico City, Mexico.

Open in Screener

DBB

Invesco DB Base Metals Fund

Feb 17 • 04:00PM ET

23.16

-0.42 -1.78 %

Financial • Exchange Traded Fund • USA • NYSE

DBB Invesco DB Base Metals Fund daily Stock Chart

Held by: HFGM GMOM TRTY CETF

Category	Commodities & Metals - Gold / Metals	Asset Type	Commodities & Metals	Tags	U.S.	Return% 1Y	25.44%	Total Holdings	8	Perf Week	-4.06%
Sponsor	Invesco	ETF Type		Tags	commodity	Return% 3Y	9.56%	AUM	299.14M	Perf Month	-4.65%
Fund Family		Bond Type		Tags	futures	Return% 5Y	9.66%	NAV/sh		Perf Quarter	9.89%
Index	Deutsche Bank Liquid Commodity Indx - Op...	Average Maturity		Tags	metals	Return% 10Y		52W High	26.02 -11.01%	Perf Half Y	21.88%
Index Weighting		Commodity Type		Tags	industrials	Return% SI		52W Low	16.67 38.92%	Perf YTD	0.96%
Active/Passive		Quant Type		Tags	-	Flows% 1M	25.56%	Volatility	1.32% 1.69%	Perf Year	23.78%
Dividend TTM	-	ESG Type		Tags	-	Flows% 3M	90.65%	ATR (14)	0.51	Perf 3Y	15.94%
Dividend Ex-Date	Dec 22, 2025	Dividend Type		Sector/Theme		Flows% YTD	44.34%	RSI (14)	44.32	Perf 5Y	30.29%
Dividend Gr. 3/5Y	- -	Structure Type		Region		Flows% 1Y		Beta	0.54	Perf 10Y	100.59%
Expense	0.75%	Growth/Value		SMA20	-3.28%	Flows% 3Y		Rel Volume	1.83	Prev Close	23.58
Inverse/Leveraged		Market Cap		SMA50	-0.25%	Flows% 5Y		Avg Volume	398.43K	Price	23.16
IPO	Jan 05, 2007	Option/Short	Yes / Yes	SMA200	13.79%	Trades		Volume	704,612	Change	-1.78%

Jan-07-26 10:21AM	'Robots & Rockets Arent Made from Hopes & Wishes,' and How the AI Revolution is Shaping the Next Metals Bull Market (Barchart)
May-02-25 07:05AM	Commodities: U.S. Sanction Threats On Iranian Oil Exports (Seeking Alpha)
Apr-28-25 06:15AM	Commodities: Oil Steady As Market Awaits Cues (Seeking Alpha)
Apr-24-25 05:50AM	Market Outlook: A Bumpy Path (Seeking Alpha)
01:55AM	Commodities: All Is Not Well Within OPEC+ (Seeking Alpha)
04:50AM	Loading…
Apr-23-25 04:50AM	Layering Import Duties In A Rapidly Changing Environment (Seeking Alpha)
Apr-16-25 03:45AM	Overall U.S. Tariff Level Still High Despite Exemptions (Seeking Alpha)
Apr-15-25 03:15PM	Tariff-Induced Sell-Off Hits Commodities (Seeking Alpha)
08:40AM	From Trade Wars To Energy Security: Mega-Force Manifestations (Seeking Alpha)
06:58AM	Oil Edges Higher Despite Demand Cuts (Seeking Alpha)
Apr-13-25 11:45PM	Commodities: Is Tariff Relief Real? (Seeking Alpha)
Apr-11-25 08:20AM	Mixed Results, Clear Signals: Navigating Resource Equities In A Shifting Macro Landscape (Seeking Alpha)
Apr-10-25 11:10AM	From OPEC To Cleantech: Key Drivers Of EM Commodities (Seeking Alpha)
01:10AM	The Tariff Pause (Seeking Alpha)
Apr-07-25 04:30AM	Tariff-Induced Commodities Sell-Off (Seeking Alpha)
04:55AM	Loading…
Apr-04-25 04:55AM	CIO Notebook: Risk Assets Under Pressure As Trump Expands Tariffs (Seeking Alpha)
Apr-03-25 04:25AM	How To Make Sense Of Trump's 'Tough Love' Tariffs (Seeking Alpha)
03:20AM	Reciprocal Tariffs Send Oil Lower (Seeking Alpha)
Apr-02-25 06:30AM	China Just Redrew The Aluminum Map, And The World Is Watching (Seeking Alpha)
Mar-25-25 02:33AM	Q1 Market Cycle Update: Probably Approaching The Peak (SeekingAlpha)
Mar-24-25 08:13AM	Monthly Commodities Tracker: March 2025 (SeekingAlpha)
Mar-22-25 01:35AM	Tariffs Vs. Commodities: A Test Of Resilience (SeekingAlpha)
Mar-21-25 09:01AM	DBB: Not The Right ETF For This Market (SeekingAlpha)
Mar-20-25 01:58PM	Exposure To Base Metals With The DBB ETF Product (SeekingAlpha)
09:20AM	Invesco American Franchise Fund Q4 2024 Commentary (SeekingAlpha)
09:05AM	Invesco Health Care Fund Q4 2024 Commentary (SeekingAlpha)
08:45AM	Invesco Global Opportunities Fund Q4 2024 Commentary (SeekingAlpha)
07:00AM	Invesco Global Fund Q4 2024 Commentary (SeekingAlpha)
06:40AM	Invesco Global Focus Fund Q4 2024 Commentary (SeekingAlpha)
06:00AM	Invesco Multi-Asset Income Fund Q4 2024 Commentary (SeekingAlpha)
03:28PM	Loading…
Mar-19-25 03:28PM	Industrial Metals Monthly: U.S. Copper Tariff Risks Pull More Metal To The U.S. (SeekingAlpha)
Dec-01-22 04:00AM	DBB: Metals ETF Ready to Rock? (ETF.com)
Apr-27-22 01:00PM	Invesco Launches EV Commodity ETF (ETF.com)
Mar-09-22 04:00AM	Metals Heating Up (ETF.com) -8.37%
Jun-22-21 11:00AM	Oil Spike Lifts Energy ETFs (ETF.com)
Jun-02-20 08:00AM	U.S. Manufacturing Points to a Recovery: 5 Winning ETF Areas (Zacks)
Oct-22-19 09:54AM	Charts Suggest Base Metals Look Poised to Move Higher (Investopedia)
Jun-25-19 09:46AM	3 Charts That Suggest Base Metals Will Shine in 2018 (Investopedia)
09:27AM	As Markets Drop, Active Traders Focus on Commodities (Investopedia)
Apr-01-19 08:00AM	Top ETF Stories of March (Zacks)
Mar-01-19 02:30PM	6 ETFs to Buy for March (Zacks)
Feb-26-19 03:00PM	Industrial Metals ETPs Are Rallying This Year (ETF Trends)
11:05AM	3 Charts That Suggest It's Time to Buy Metals (Investopedia)
Jan-11-19 11:52AM	What Metals Are Saying About Rates (Investopedia)
Jul-26-18 11:09AM	4 Commodity ETFs Worst Hit by Ongoing Trade Turmoil (InvestorPlace)
Jul-12-18 11:05AM	4 Commodity ETFs Worst Hit by Ongoing Trade Turmoil (Zacks)
Apr-03-18 10:33AM	As Markets Drop, Active Traders Focus on Commodities (Investopedia)
Jan-25-18 10:34AM	Can Copper Provide Upside to BHP Billiton in Fiscal 2018? (Market Realist)
Jan-09-18 09:45AM	3 Charts That Suggest Base Metals Will Shine in 2018 (Investopedia)
Jan-02-18 07:09AM	Three Important Stock Charts to Kick Off 2018 (InvestorPlace)
Dec-14-17 05:25PM	Commodity ETFs to Buy for 2018? (Zacks)
Dec-12-17 09:02AM	Vale to Preserve Nickel Optionality: Expects Electric Car Boom (Market Realist)
Nov-20-17 03:33PM	Iron Fist, Velvet Glove: Why Vale Can Gain 40% (Barrons.com)
Nov-08-17 07:33AM	How Higher Base Metals Prices Supported Vales Earnings (Market Realist)
Oct-23-17 01:33PM	Why These Commodity ETFs Are on a Tear (Zacks)
Aug-24-17 10:35AM	How Alumina Prices Affect Century Aluminum (Market Realist)
Aug-23-17 02:04PM	Base Metal ETFs Buck Commodity Swoon (ETF.com)
Aug-16-17 05:12PM	ETF Topper: Metals and Miners Shine (Barrons.com)
Aug-11-17 12:27PM	Commodities Are Mixed in the Early Hours of August 11 (Market Realist)
Aug-10-17 08:49AM	Commodities Are Strong in the Early Hours on August 10 (Market Realist)
Aug-09-17 08:16AM	Breakouts in Base Metals Suggest It Is Time to Buy (Investopedia)
Aug-08-17 12:05PM	Chinas Aluminum Exports Fall from Highsa Relief for Alcoa (Market Realist)
Jul-27-17 11:47AM	Indian Equities Continue to Attract Investor Attention in July (Market Realist)
Jul-24-17 08:58AM	Commodities Were Mixed Last Week, Dollar Lent Support (Market Realist)
Jul-21-17 11:16AM	Commodities Are Mixed in the Early Hours on July 21 (Market Realist)
Jul-19-17 08:08AM	Commodities Are Mixed in the Early Hours on July 19 (Market Realist)
Jul-18-17 09:19AM	Commodities Are Stable Early on July 18 (Market Realist)
Jul-17-17 10:11AM	Mixed Commodities and Weaker Crude Oil in the Early Hours (Market Realist)
Jul-14-17 10:01AM	Commodities Are Strong on July 14, Supported by the Weak Dollar (Market Realist)
Jul-13-17 09:30AM	Mixed Commodities and Weak Crude Oil Early on July 13 (Market Realist)
Jul-10-17 11:43AM	Commodities Are Weaker, Crude Oil Falls amid Supply Concerns (Market Realist)
Jul-07-17 09:52AM	Commodities Are Weaker in the Early Hours on July 7 (Market Realist)
Jul-06-17 09:13AM	Commodities Are Stable in the Early Hours on July 6 (Market Realist)
07:40AM	Commodities Are Weaker amid the Firmer Dollar (Market Realist)
Jul-05-17 03:48PM	Plan for 'Commodity Rally 2.0 (Barrons.com)
Jun-29-17 10:10AM	Commodities Are Mixed Early on June 29 (Market Realist)
Jun-28-17 08:29AM	Commodities Are Mixed, Weaker Dollar Supports Gold (Market Realist)
07:36AM	How Are Analysts Rating Southern Copper in 2Q17? (Market Realist)
Jun-27-17 10:18AM	Commodities Are Stable in the Early Hours on June 27 (Market Realist)
07:38AM	Commodities Were Mixed in the Week Ending June 23 (Market Realist)
Jun-26-17 10:03AM	Commodities Are Mixed, Dollar Weighs on Precious Metals (Market Realist)
Jun-23-17 10:13AM	Commodities Are Stable in the Early Hours, Dollar Pulled Back (Market Realist)
Jun-21-17 10:34AM	Commodities Are Stable in the Early Hours on June 21 (Market Realist)
Jun-19-17 07:36AM	The Truth behind 2017 Copper Inventories (Market Realist)
Jun-15-17 09:49AM	Commodities Are Weaker in the Early Hours on June 15 (Market Realist)
Jun-13-17 09:01AM	Commodities Are Mixed, Gold Is Weaker before the Feds Meeting (Market Realist)
Jun-09-17 10:36AM	Why Alumina Prices Are a Challenge for Alcoa (Market Realist)
Jun-06-17 08:55AM	Commodities Are Mixed, Crude Oil Fell amid Middle East Concerns (Market Realist)
Jun-02-17 09:16AM	Why Are Commodities Weaker in the Early Hours on June 2? (Market Realist)
May-31-17 08:14AM	Commodities Are Mixed on May 31, Crude Oil Is at 2-Week Lows (Market Realist)
May-30-17 07:38AM	Mixed Commodities and Weaker Crude Oil Early on May 29 (Market Realist)
May-26-17 08:09AM	Commodities Are Mixed, Crude Oil Is Stable in the Early Hours (Market Realist)
May-24-17 01:35PM	Should Lower Alumina Prices Bother Alcoa and Other Producers? (Market Realist)
08:50AM	Commodities Are Mixed, Gold Awaits the FOMCs Minutes (Market Realist)
May-23-17 08:21AM	Now Is the Time to Buy Base Metals (JJM, DBB) (Investopedia)
May-22-17 07:46AM	Commodities Are Stable, Crude Oil Rose Due to Increased Optimism (Market Realist)
May-19-17 08:14AM	Commodities Are Stable in the Early Hours, Gold Struggles (Market Realist)
May-18-17 08:40AM	Commodities Are Weaker, Gold Is Stable amid US Political Jitters (Market Realist)
May-15-17 08:02AM	Commodities Are Stable, Crude Oil Rose to 3-Week Highs (Market Realist)
May-12-17 08:27AM	Commodities Are Mixed, Crude Oil Awaits Rig Count Data (Market Realist)

Invesco DB Base Metals Fund seeks to track the DBIQ Optimum Yield Industrial Metals Index Excess Return (DBIQ-OY Industrial Metals ER), which is intended to reflect the base metals sector. The index Commodities consist of Aluminum, Zinc and Copper - Grade A. The fund invests in futures contracts in an attempt to track its corresponding index.

open in screener | open in yahoo | open in marketwatch | open in google | open in EDGAR

Open in Screener

CORT

Corcept Therapeutics Inc

Feb 17 • 04:00PM ET

39.63

-0.34 -0.85 %

Healthcare • Biotechnology • USA • NASD

CORT Corcept Therapeutics Inc daily Stock Chart

Peers: NBIX SRPT TGTX MDGL ARDX ANAB VKTX AKBA LGND PSTV

| Held by: IJR VTI FBT VB VBK VXF SPSM IJT IWP XSMO

Index	-	P/E	45.28	EPS (ttm)	0.88	Insider Own	11.88%	Shs Outstand	105.12M	Perf Week	-4.07%
Market Cap	4.17B	Forward P/E	92.19	EPS next Y	0.43	Insider Trans	-3.04%	Shs Float	92.69M	Perf Month	11.98%
Enterprise Value	3.75B	PEG	3.82	EPS next Q	0.33	Inst Own	72.99%	Short Float	10.01%	Perf Quarter	-47.68%
Income	104.65M	P/S	5.62	EPS this Y	-22.28%	Inst Trans	-2.53%	Short Ratio	4.95	Perf Half Y	-44.76%
Sales	741.17M	P/B	6.59	EPS next Y	-55.03%	ROA	13.02%	Short Interest	9.28M	Perf YTD	13.88%
Book/sh	6.01	P/C	9.89	EPS next 5Y	24.14%	ROE	16.47%	52W High	117.33 -66.22%	Perf Year	-45.50%
Cash/sh	4.01	P/FCF	25.64	EPS past 3/5Y	11.29% 9.89%	ROIC	16.42%	52W Low	32.99 20.13%	Perf 3Y	75.90%
Dividend Est.	-	EV/EBITDA	55.65	Sales past 3/5Y	22.64% 17.11%	Gross Margin	98.19%	Volatility	3.91% 5.38%	Perf 5Y	43.02%
Dividend TTM	-	EV/Sales	5.06	EPS Y/Y TTM	-26.13%	Oper. Margin	8.85%	ATR (14)	2.66	Perf 10Y	916.15%
Dividend Ex-Date	-	Quick Ratio	3.07	Sales Y/Y TTM	17.92%	Profit Margin	14.12%	RSI (14)	39.89	Recom	1.86
Dividend Gr. 3/5Y	- -	Current Ratio	3.14	EPS Q/Q	-60.52%	SMA20	-3.44%	Beta	0.27	Target Price	84.00
Payout	0.00%	Debt/Eq	0.01	Sales Q/Q	13.75%	SMA50	-28.03%	Rel Volume	0.46	Prev Close	39.97
Employees	500	LT Debt/Eq	0.01	Earnings	Feb 24 AMC	SMA200	-42.86%	Avg Volume	1.88M	Price	39.63
IPO	Apr 14, 2004	Option/Short	Yes / Yes	EPS/Sales Surpr.	-2.26% -6.96%	Trades		Volume	840,225	Change	-0.85%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-31-25	Downgrade	Wolfe Research	Peer Perform → Underperform	$30
Dec-16-25	Initiated	UBS	Neutral
Nov-18-25	Initiated	Wolfe Research	Peer Perform
Nov-06-23	Upgrade	Truist	Hold → Buy	$29 → $38
Apr-11-23	Initiated	SVB Securities	Market Perform	$25
Apr-04-23	Initiated	Piper Sandler	Overweight	$27
Feb-15-23	Downgrade	Jefferies	Buy → Hold	$35 → $22
Aug-01-22	Downgrade	Truist	Buy → Hold	$30
Jul-27-22	Upgrade	Jefferies	Hold → Buy	$21 → $35
Jun-27-22	Resumed	Canaccord Genuity	Buy	$30 → $34
Feb-02-22	Initiated	Canaccord Genuity	Buy	$30
Jan-28-22	Initiated	Truist	Buy	$30
Aug-05-20	Downgrade	Jefferies	Buy → Hold	$16
Sep-24-19	Initiated	Jefferies	Buy	$20
Sep-06-19	Initiated	H.C. Wainwright	Buy	$18
Feb-04-19	Downgrade	B. Riley FBR	Buy → Neutral	$22 → $12
Aug-10-18	Reiterated	Stifel	Hold	$20 → $11
May-31-18	Downgrade	Stifel	Buy → Hold	$20
Mar-09-18	Initiated	B. Riley FBR, Inc.	Buy	$30
Aug-31-17	Initiated	Stifel	Buy	$20

Show Previous Ratings

Feb-17-26 04:05PM	Corcept Therapeutics to Announce Fourth Quarter and Full-Year 2025 Financial Results, Provide Corporate Update and Host Conference Call (Business Wire)
Feb-16-26 12:24PM	FDA-Issued CRL for Relacorilant NDA Leads to Bullish Views Around Corcept Therapeutics (CORT) (Insider Monkey)
Feb-04-26 03:31PM	Lost Money on Corcept Therapeutics Incorporated (CORT)? Possible Fraud - Contact Levi & Korsinsky Today (Newsfile)
Jan-30-26 08:32PM	Hagens Berman Investigating Corcept Therapeutics (CORT): Shares Fall After Report That FDA Warned Against Relacorilant Drug Application Filing (Business Wire) -10.63%
Jan-25-26 06:44PM	Corcept Therapeutics (CORT) Climbs 26.6% on Stellar Clinical Trial Result (Insider Monkey)
01:55PM	Loading…
Jan-23-26 01:55PM	Silver Breaks $101, Intel Stock Plunges 17%: What's Moving Markets Friday? (Benzinga) +6.49%
11:13AM	CORT Rises as Relacorilant Meets OS Endpoint in Ovarian Cancer Study (Zacks)
08:11AM	Corcept Therapeutics (CORT) Climbs 13.7% on Strong Clinical Trial Results (Insider Monkey)
05:27AM	Novo climbs higher on strong Wegovy pill launch; Terns tweaks leukemia drug deal (BioPharma Dive)
Jan-22-26 04:05PM	Why Former Highflier Corcept Therapeutics Just Surged Again (Investor's Business Daily) +13.74%
03:06PM	Russell 2000 Extends Records, Meta Jumps 5%: What's Moving Markets Thursday? (Benzinga)
01:07PM	Corcepts stock up as relacorilant meets OS goal in Phase III ovarian cancer trial (Clinical Trials Arena)
11:12AM	Corcept Therapeutics Experimental Lead Drug Cuts Death Risk By 35% In Advanced Ovarian Cancer Patients, Stock Jumps (Benzinga)
08:00AM	Overall Survival Primary Endpoint Met in Corcept's Pivotal Phase 3 ROSELLA Trial of Relacorilant in Patients with Platinum-Resistant Ovarian Cancer (Business Wire)
Jan-15-26 08:15AM	Is Corcept Therapeutics Incorporated (CORT) The Most Promising Growth Stock According to Analysts? (Insider Monkey)
06:47AM	Loading…
06:47AM	One Rare Disease Biotech Posts 97% Margins but the Faster Growing Rival Just Turned Its First Profit (24/7 Wall St.)
Jan-14-26 11:56AM	Corcept Therapeutics (CORT) Faces Investor Scrutiny Amid Receipt of FDA Complete Response Letter For Relacorilant, Shares Tank 50% - Hagens Berman (PR Newswire)
Jan-09-26 03:16AM	Price Targets Lowered on Corcept Therapeutics (CORT) After FDA Letter (Insider Monkey)
Jan-06-26 12:01PM	Corcept Therapeutics (CORT) Faces Investor Scrutiny Amid Receipt of FDA Complete Response Letter For Relacorilant, Shares Tank 50% - Hagens Berman (PR Newswire)
Jan-05-26 11:31PM	1 Healthcare Stock to Target This Week and 2 We Turn Down (StockStory) -8.51%
12:16PM	Why Corcept (CORT) Stock Is Trading Lower Today (StockStory)
09:54AM	Corcept (CORT) Surges 9.8%: Is This an Indication of Further Gains? (Zacks)
Jan-02-26 11:17AM	The FDA Just Snubbed Corcept Therapeutics. Should You Buy the Dip in CORT Stock or Stay Far Away (Barchart) +9.77%
10:22AM	Corcept Tanks on FDA's CRL to Relacorilant NDA in Hypercortisolism (Zacks)
08:50AM	Implied Volatility Surging for Corcept Stock Options (Zacks)
07:30AM	Company News for Jan 2, 2026 (Zacks)
Jan-01-26 08:10AM	FDA says it needs additional evidence of effectiveness for Corcept relacorilant (TipRanks)
Dec-31-25 06:41PM	Why Corcept Therapeutics Plummeted by 50% Today (Motley Fool) -50.42% +9.77%
05:00PM	Why Corcept (CORT) Shares Are Falling Today (StockStory)
04:34PM	Stocks Settle Lower on Tech Weakness and Higher Bond Yields (Barchart)
12:31PM	Loading…
12:31PM	Corcept Therapeutics Shares Plunge 50% After FDA Rejects Blood Pressure Drug (Barrons.com)
10:00AM	Corcept Sinks After FDA Rejects Drug to Treat Hypertension (Bloomberg)
09:57AM	Stocks Slide on Weakness in Megacap Tech Stocks (Barchart)
08:00AM	Corcept Receives Complete Response Letter for Relacorilant as a Treatment for Patients with Hypercortisolism (Business Wire)
Dec-30-25 06:32AM	Stock Market Today: Stocks Struggling to Finish 2025 on High Note (TheStreet) -12.06%
Dec-23-25 03:51PM	Why Corcept (CORT) Stock Is Trading Lower Today (StockStory)
Dec-21-25 08:56AM	Corcept Therapeutics (CORT): Analyst Says Shares Pricing in Growth, New Launch (Insider Monkey)
Dec-16-25 11:03PM	Corcept (CORT): Buy, Sell, or Hold Post Q3 Earnings? (StockStory) -7.08%
02:05PM	Why Corcept (CORT) Stock Is Down Today (StockStory)
Dec-11-25 07:44AM	Wall Street Firms Tout Corcept Therapeutics Incorporated (CORT) Prospects on Korlym Medication Prospects (Insider Monkey)
Dec-10-25 11:30AM	Theravance Bio (TBPH) Down 3.7% Since Last Earnings Report: Can It Rebound? (Zacks)
Dec-07-25 10:33PM	Analysts See 70% Upside Potential in Corcept Therapeutics (CORT) Stock (Insider Monkey)
Dec-04-25 11:30AM	Corcept (CORT) Up 9.2% Since Last Earnings Report: Can It Continue? (Zacks)
Dec-01-25 11:04AM	Will Korlym Continue to Drive Corcept's Top Line in 2026? (Zacks)
Nov-26-25 02:59PM	Corcept Therapeutics Incorporated (CORT) Modifies Revenue Guidance while Banking on Cushing Syndrome Treatment for Growth (Insider Monkey)
Nov-12-25 10:34PM	Branded Pharmaceuticals Stocks Q3 Recap: Benchmarking Corcept (NASDAQ:CORT) (StockStory)
Nov-11-25 12:36AM	The 5 Most Interesting Analyst Questions From Corcept's Q3 Earnings Call (StockStory)
Nov-05-25 10:01AM	Corcept Q3 Earnings & Revenues Lag Estimates, '25 View Cut, Stock Down (Zacks) +7.81%
08:31AM	CORT Q3 Deep Dive: Pharmacy Transition and Pipeline Expansion Drive Mixed Outlook (StockStory)
12:10AM	Corcept Therapeutics Inc (CORT) Q3 2025 Earnings Call Highlights: Revenue Growth Amidst Net ... (GuruFocus.com)
Nov-04-25 06:25PM	Corcept Therapeutics (CORT) Q3 Earnings and Revenues Miss Estimates (Zacks)
06:00PM	Corcept (NASDAQ:CORT) Reports Sales Below Analyst Estimates In Q3 Earnings (StockStory)
05:20PM	Corcept: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Corcept Therapeutics Announces Third Quarter Financial Results, Oncology Development Programs and Provides Corporate Update (Business Wire)
09:36AM	What Does Wall Street Think About Corcept Therapeutics (CORT)? (Insider Monkey)
Nov-02-25 10:04PM	Corcept Earnings: What To Look For From CORT (StockStory)
Oct-29-25 10:00AM	NewAmsterdam Pharma Company N.V. (NAMS) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Oct-28-25 04:05PM	Corcept Therapeutics to Announce Third Quarter Financial Results, Provide Corporate Update and Host Conference Call (Business Wire)
Oct-22-25 10:00AM	Analysts Estimate Corcept Therapeutics (CORT) to Report a Decline in Earnings: What to Look Out for (Zacks)
Oct-19-25 05:15AM	Corcept Presents ESMO 2025 Late-Breaker: Relacorilant Demonstrates Benefit in Patients with Platinum-Resistant Ovarian Cancer with Prior PARP Inhibitor Treatment (Business Wire)
Oct-17-25 09:54PM	H.C. Wainwright Remains Bullish on Corcept Therapeutics Incorporated (CORT) (Insider Monkey)
Oct-15-25 02:02PM	Corcept (CORT) Shares Skyrocket, What You Need To Know (StockStory) +6.50%
11:35AM	CORT Files MAA for Relacorilant in Platinum-Resistant Ovarian Cancer (Zacks)
Oct-14-25 08:00AM	Corcept Submits Marketing Authorization Application to European Medicines Agency for Relacorilant as a Treatment for Patients with Platinum-Resistant Ovarian Cancer (Business Wire)
Oct-10-25 11:51AM	Why Corcept (CORT) Shares Are Falling Today (StockStory) -16.30%
Oct-03-25 08:21AM	Here's What Makes Corcept Therapeutics (CORT) an Attractive Investment? (Insider Monkey)
Oct-01-25 04:01PM	Why Corcept (CORT) Stock Is Trading Up Today (StockStory)
10:40AM	Can Relacorilant Drive Corcept's Long-Term Growth Beyond Korlym? (Zacks)
Sep-29-25 07:20PM	Corcept Therapeutics Beats Q2 Estimates, Cuts Guidance and Advances NDA for New Cancer Drug (Insider Monkey)
Sep-24-25 04:06AM	FDA Accepts New Drug Application for Corcept Therapeutics's (CORT) Relacorilant (Insider Monkey)
Sep-23-25 03:25PM	Why Are Corcept (CORT) Shares Soaring Today (StockStory)
Sep-22-25 02:30PM	Corcept to Present New Late-Breaking Data From Pivotal ROSELLA Trial of Relacorilant in Platinum-Resistant Ovarian Cancer at ESMO 2025 (Business Wire)
Sep-16-25 12:02AM	Corcept (CORT): Buy, Sell, or Hold Post Q2 Earnings? (StockStory)
Sep-15-25 11:36PM	Q2 Earnings Roundup: Corcept (NASDAQ:CORT) And The Rest Of The Branded Pharmaceuticals Segment (StockStory)
02:18PM	11 fast-growing small-cap stocks that could get a boost from the Fed's next move (MarketWatch)
Sep-11-25 11:57AM	FDA Accepts Corcept's NDA for Relacorilant in Ovarian Cancer (Zacks)
03:31AM	Corcept's (CORT) Multibagger Momentum Builds on Relacorilant and Expanding Commercial Footprint (Insider Monkey)
Sep-10-25 08:00AM	FDA Files Corcept's New Drug Application for Relacorilant as a Treatment for Patients with Platinum-Resistant Ovarian Cancer (Business Wire)
Sep-02-25 09:58AM	Can Korlym Drive Corcept's Growth Through the Rest of 2025? (Zacks)
Aug-25-25 02:03PM	Corcept Shares Rise 39.6% in YTD: How Should You Play the Stock? (Zacks)
Aug-22-25 11:57PM	Canaccord Genuity Maintains a Buy on Corcept Therapeutics (CORT), Retains a $137 PT (Insider Monkey)
Aug-13-25 12:25AM	5 Must-Read Analyst Questions From Corcept's Q2 Earnings Call (StockStory)
12:00AM	CORT Q2 Deep Dive: Product Supply Constraints and Pipeline Progress Reshape Outlook (StockStory)
Aug-01-25 12:04PM	CORT's Q2 Earnings Top Mark, Revenues Lag, '25 View Cut, Stock Down (Zacks)
Jul-31-25 05:35PM	Corcept Therapeutics (CORT) Tops Q2 Earnings Estimates (Zacks)
05:27PM	Corcept (NASDAQ:CORT) Misses Q2 Sales Targets (StockStory)
04:36PM	Corcept: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Corcept Therapeutics Announces Second Quarter Financial Results and Provides Corporate Update (Business Wire)
Jul-29-25 11:05PM	What To Expect From Corcept's (CORT) Q2 Earnings (StockStory)
Jul-28-25 02:07AM	H.C. Wainwright Remains Bullish on Corcept Therapeutics Incorporated (CORT) (Insider Monkey)
Jul-27-25 09:58AM	Corcept Therapeutics Advances Pipeline Fueling Growth With Controlled Risk (Insider Monkey)
Jul-24-25 11:48PM	Corcept (CORT) Advances Ovarian Cancer Therapy with FDA Filing for Relacorilant (Insider Monkey)
04:05PM	Corcept Therapeutics to Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference Call (Business Wire)
Jul-23-25 11:00AM	Corcept Advances Cancer Drug as Analysts Back Strong Growth Prospects (Insider Monkey)
Jul-17-25 07:10AM	Madrigal (MDGL) Moves 10.9% Higher: Will This Strength Last? (Zacks)
12:08AM	3 Reasons CORT is Risky and 1 Stock to Buy Instead (StockStory)
Jul-15-25 10:17AM	Corcept Seeks FDA Approval for Relacorilant in Ovarian Cancer (Zacks)
Jul-14-25 08:00AM	Corcept Submits New Drug Application for Relacorilant as a Treatment for Patients with Platinum-Resistant Ovarian Cancer (Business Wire)
Jul-06-25 04:15AM	Corcept Therapeutics (CORT) Announces Pivotal Data from Phase 3 ROSELLA Trial (Insider Monkey)
Jul-04-25 01:48AM	Corcept Therapeutics' Korlym Shows Glucose Control, Weight Reduction in Hypercortisolism, Type 2 Diabetes Patients (Insider Monkey)

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Hunt Hazel	Chief Scientific Officer	Feb 09 '26	Option Exercise	3.88	150,000	582,000	333,405	Feb 11 05:26 PM
Guyer William	Chief Development Officer	Feb 03 '26	Option Exercise	21.65	20,000	433,000	21,235	Feb 05 05:42 PM
Guyer William	Chief Development Officer	Feb 03 '26	Sale	40.87	20,000	817,334	1,235	Feb 05 05:42 PM
Guyer William	Officer	Feb 03 '26	Proposed Sale	40.71	20,000	814,200		Feb 03 11:26 AM
BAKER G LEONARD JR	Director	Jan 27 '26	Option Exercise	11.49	140,000	1,608,700	1,095,262	Jan 29 04:10 PM
Guyer William	Chief Development Officer	Jan 06 '26	Option Exercise	21.65	20,000	433,000	21,235	Jan 08 08:35 PM
Guyer William	Chief Development Officer	Jan 06 '26	Sale	35.18	20,000	703,656	1,235	Jan 08 08:35 PM
Guyer William	Officer	Jan 06 '26	Proposed Sale	34.95	20,000	699,000		Jan 06 12:04 PM
Robb Gary Charles	Chief Business Officer	Dec 24 '25	Option Exercise	3.88	145,000	562,600	158,910	Dec 29 05:58 PM
BELANOFF JOSEPH K	Chief Executive Officer	Dec 24 '25	Option Exercise	3.88	550,000	2,134,000	550,000	Dec 29 05:24 PM
Guyer William	Chief Development Officer	Dec 02 '25	Option Exercise	21.65	20,000	433,000	21,235	Dec 03 09:19 PM
Guyer William	Chief Development Officer	Dec 02 '25	Sale	80.08	20,000	1,601,526	1,235	Dec 03 09:19 PM
Maduck Sean	See Remarks	Dec 01 '25	Option Exercise	8.27	20,000	165,400	27,904	Dec 03 08:53 PM
Maduck Sean	See Remarks	Dec 01 '25	Sale	79.52	20,000	1,590,490	7,904	Dec 03 08:53 PM
Lyon Joseph Douglas	See Remarks	Dec 01 '25	Option Exercise	13.56	5,000	67,800	15,277	Dec 03 08:36 PM
Lyon Joseph Douglas	See Remarks	Dec 01 '25	Sale	79.53	5,000	397,632	10,277	Dec 03 08:36 PM
BELANOFF JOSEPH K	Chief Executive Officer	Dec 01 '25	Sale	79.77	40,000	3,190,796	2,701,370	Dec 03 08:14 PM
Guyer William	Officer	Dec 02 '25	Proposed Sale	79.78	20,000	1,595,600		Dec 02 10:34 AM
BELANOFF JOSEPH K	Officer	Dec 01 '25	Proposed Sale	79.40	40,000	3,176,000		Dec 01 02:36 PM
Maduck Sean	Officer	Dec 01 '25	Proposed Sale	79.40	20,000	1,588,000		Dec 01 02:00 PM
Lyon Joseph Douglas	Officer	Dec 01 '25	Proposed Sale	79.40	5,000	397,000		Dec 01 01:50 PM
Guyer William	Chief Development Officer	Nov 25 '25	Sale	80.90	4,500	364,070	787	Nov 26 05:22 PM
Guyer William	Officer	Nov 25 '25	Proposed Sale	80.90	4,500	364,070		Nov 25 04:46 PM
Guyer William	Chief Development Officer	Nov 05 '25	Option Exercise	21.65	20,000	433,000	25,287	Nov 07 05:10 PM
Guyer William	Chief Development Officer	Nov 05 '25	Sale	75.36	20,000	1,507,122	5,287	Nov 07 05:10 PM
Lyon Joseph Douglas	See Remarks	Nov 03 '25	Option Exercise	13.56	5,000	67,800	15,277	Nov 05 07:59 PM
Lyon Joseph Douglas	See Remarks	Nov 03 '25	Sale	73.65	5,000	368,244	10,277	Nov 05 07:59 PM
BELANOFF JOSEPH K	Chief Executive Officer	Nov 05 '25	Sale	74.77	28,782	2,152,105	2,741,370	Nov 05 07:57 PM
BELANOFF JOSEPH K	Chief Executive Officer	Nov 03 '25	Sale	74.08	11,218	831,014	2,770,152	Nov 05 07:57 PM
Maduck Sean	See Remarks	Nov 03 '25	Option Exercise	8.27	20,000	165,400	27,904	Nov 05 07:56 PM
Maduck Sean	See Remarks	Nov 03 '25	Sale	73.99	20,000	1,479,816	7,904	Nov 05 07:56 PM
Guyer William	Officer	Nov 05 '25	Proposed Sale	71.10	20,000	1,422,000		Nov 05 10:12 AM
BELANOFF JOSEPH K	Officer	Nov 03 '25	Proposed Sale	73.47	40,000	2,938,800		Nov 03 04:06 PM
Lyon Joseph Douglas	Officer	Nov 03 '25	Proposed Sale	73.47	5,000	367,350		Nov 03 03:31 PM
Maduck Sean	Officer	Nov 03 '25	Proposed Sale	73.47	20,000	1,469,400		Nov 03 03:25 PM
Swisher Daniel N JR	Director	Oct 10 '25	Option Exercise	14.08	2,200	30,976	2,200	Oct 15 06:31 PM
Swisher Daniel N JR	Director	Oct 10 '25	Sale	87.54	2,200	192,588	0	Oct 15 06:31 PM
Swisher Daniel N JR	Director	Oct 10 '25	Proposed Sale	87.54	2,200	192,588		Oct 10 10:44 AM
Guyer William	Chief Development Officer	Oct 07 '25	Option Exercise	21.65	20,000	433,000	25,287	Oct 09 05:51 PM
Guyer William	Chief Development Officer	Oct 07 '25	Sale	89.94	20,000	1,798,782	5,287	Oct 09 05:51 PM
Guyer William	Officer	Oct 07 '25	Proposed Sale	89.85	20,000	1,797,000		Oct 07 01:51 PM
BELANOFF JOSEPH K	Chief Executive Officer	Oct 01 '25	Sale	85.08	40,000	3,403,253	2,781,370	Oct 03 05:24 PM
Lyon Joseph Douglas	See Remarks	Oct 01 '25	Option Exercise	13.56	5,000	67,800	15,277	Oct 03 05:17 PM
Lyon Joseph Douglas	See Remarks	Oct 01 '25	Sale	84.75	5,000	423,766	10,277	Oct 03 05:17 PM
Maduck Sean	See Remarks	Oct 01 '25	Option Exercise	7.95	20,000	159,005	27,904	Oct 03 05:15 PM
Maduck Sean	See Remarks	Oct 01 '25	Sale	85.06	20,000	1,701,232	7,904	Oct 03 05:15 PM
BELANOFF JOSEPH K	Officer	Oct 01 '25	Proposed Sale	83.11	40,000	3,324,400		Oct 01 03:34 PM
Maduck Sean	Officer	Oct 01 '25	Proposed Sale	83.11	20,000	1,662,200		Oct 01 01:54 PM
Lyon Joseph Douglas	Officer	Oct 01 '25	Proposed Sale	83.11	5,000	415,550		Oct 01 01:42 PM
Swisher Daniel N JR	Director	Sep 10 '25	Option Exercise	14.08	2,200	30,976	2,200	Sep 11 08:38 PM
Swisher Daniel N JR	Director	Sep 10 '25	Sale	72.45	2,200	159,390	0	Sep 11 08:38 PM
Swisher Daniel N JR	Director	Sep 10 '25	Proposed Sale	72.45	2,200	159,390		Sep 10 09:50 AM
Cannon Gillian	Director	Sep 04 '25	Option Exercise	22.99	11,000	252,890	11,000	Sep 08 08:20 PM
Guyer William	Chief Development Officer	Sep 02 '25	Option Exercise	21.65	20,000	433,000	25,487	Sep 04 07:59 PM
Guyer William	Chief Development Officer	Sep 02 '25	Sale	70.49	20,000	1,409,848	5,487	Sep 04 07:59 PM
Lyon Joseph Douglas	See Remarks	Sep 02 '25	Option Exercise	13.56	5,000	67,800	15,066	Sep 04 07:56 PM
Lyon Joseph Douglas	See Remarks	Sep 02 '25	Sale	70.25	5,000	351,247	10,066	Sep 04 07:56 PM
Maduck Sean	See Remarks	Sep 02 '25	Option Exercise	5.05	20,000	101,000	27,681	Sep 04 07:54 PM
Maduck Sean	See Remarks	Sep 02 '25	Sale	70.49	20,000	1,409,828	7,681	Sep 04 07:54 PM
BELANOFF JOSEPH K	Chief Executive Officer	Sep 02 '25	Sale	70.53	40,000	2,821,033	2,821,370	Sep 04 07:54 PM
Guyer William	Officer	Sep 02 '25	Proposed Sale	69.72	20,000	1,394,400		Sep 02 04:31 PM
Maduck Sean	Officer	Sep 02 '25	Proposed Sale	69.72	20,000	1,394,400		Sep 02 04:23 PM
Lyon Joseph Douglas	Officer	Sep 02 '25	Proposed Sale	69.72	5,000	348,600		Sep 02 04:16 PM
BELANOFF JOSEPH K	Officer	Sep 02 '25	Proposed Sale	69.72	40,000	2,788,800		Sep 02 04:09 PM
Robb Gary Charles	Chief Business Officer	Aug 22 '25	Option Exercise	3.88	5,000	19,400	18,364	Aug 26 06:56 PM
Robb Gary Charles	Chief Business Officer	Aug 22 '25	Sale	71.27	2,326	165,774	16,038	Aug 26 06:56 PM
Robb Gary Charles	Officer	Aug 22 '25	Proposed Sale	71.27	2,326	165,774		Aug 22 10:58 AM
Swisher Daniel N JR	Director	Aug 11 '25	Option Exercise	14.08	2,200	30,976	2,200	Aug 12 07:22 PM
Swisher Daniel N JR	Director	Aug 11 '25	Sale	72.30	2,200	159,060	0	Aug 12 07:22 PM
Guyer William	Chief Development Officer	Aug 08 '25	Option Exercise	21.65	35,007	757,902	40,494	Aug 12 07:19 PM
Guyer William	Chief Development Officer	Aug 08 '25	Sale	71.77	35,007	2,512,452	5,487	Aug 12 07:19 PM
Swisher Daniel N JR	Director	Aug 11 '25	Proposed Sale	72.30	2,200	159,060		Aug 11 10:20 AM
Guyer William	Chief Development Officer	Aug 05 '25	Option Exercise	21.65	14	303	5,501	Aug 07 07:17 PM
Guyer William	Chief Development Officer	Aug 05 '25	Sale	71.77	14	1,005	5,487	Aug 07 07:17 PM
Maduck Sean	See Remarks	Aug 01 '25	Option Exercise	5.05	35,007	176,785	42,688	Aug 05 06:51 PM
Maduck Sean	See Remarks	Aug 01 '25	Sale	67.79	35,007	2,373,237	7,681	Aug 05 06:51 PM
BELANOFF JOSEPH K	Chief Executive Officer	Aug 01 '25	Sale	68.53	40,000	2,741,207	2,861,370	Aug 05 06:51 PM
Lyon Joseph Douglas	See Remarks	Aug 01 '25	Option Exercise	13.56	5,823	78,960	15,889	Aug 05 06:47 PM
Lyon Joseph Douglas	See Remarks	Aug 01 '25	Sale	67.51	5,823	393,128	10,066	Aug 05 06:47 PM
Guyer William	Officer	Aug 05 '25	Proposed Sale	71.77	20,000	1,435,400		Aug 05 01:05 PM
Lyon Joseph Douglas	Officer	Aug 01 '25	Proposed Sale	67.17	5,000	335,850		Aug 01 11:25 AM
Maduck Sean	Officer	Aug 01 '25	Proposed Sale	67.15	20,000	1,343,000		Aug 01 11:11 AM
BELANOFF JOSEPH K	Officer	Aug 01 '25	Proposed Sale	67.17	615	41,310		Aug 01 11:00 AM
Maduck Sean	See Remarks	Jul 17 '25	Option Exercise	5.05	4,315	21,791	22,020	Jul 21 07:14 PM
Maduck Sean	See Remarks	Jul 18 '25	Option Exercise	5.05	473	2,389	18,178	Jul 21 07:14 PM
Maduck Sean	See Remarks	Jul 17 '25	Sale	73.48	4,315	317,054	17,705	Jul 21 07:14 PM
Maduck Sean	See Remarks	Jul 18 '25	Sale	73.44	473	34,737	17,705	Jul 21 07:14 PM
BELANOFF JOSEPH K	Chief Executive Officer	Jul 17 '25	Sale	73.69	615	45,318	2,901,370	Jul 21 07:11 PM
Lyon Joseph Douglas	See Remarks	Jul 17 '25	Option Exercise	13.56	3,877	52,572	13,943	Jul 21 07:10 PM
Lyon Joseph Douglas	See Remarks	Jul 18 '25	Option Exercise	13.56	200	2,712	10,266	Jul 21 07:10 PM
Lyon Joseph Douglas	See Remarks	Jul 17 '25	Sale	73.48	3,877	284,864	10,066	Jul 21 07:10 PM
Lyon Joseph Douglas	See Remarks	Jul 18 '25	Sale	73.40	200	14,680	10,066	Jul 21 07:10 PM
Guyer William	Chief Development Officer	Jul 17 '25	Option Exercise	21.65	4,379	94,805	9,866	Jul 21 07:10 PM
Guyer William	Chief Development Officer	Jul 18 '25	Option Exercise	21.65	500	10,825	5,987	Jul 21 07:10 PM
Guyer William	Chief Development Officer	Jul 17 '25	Sale	73.48	4,379	321,774	5,487	Jul 21 07:10 PM
Guyer William	Chief Development Officer	Jul 18 '25	Sale	73.44	500	36,721	5,487	Jul 21 07:10 PM
BELANOFF JOSEPH K	Officer	Jul 17 '25	Proposed Sale	72.85	40,000	2,914,000		Jul 17 04:00 PM
Swisher Daniel N JR	Director	Jul 10 '25	Option Exercise	14.08	2,200	30,976	2,200	Jul 14 04:36 PM
Swisher Daniel N JR	Director	Jul 10 '25	Sale	71.08	2,200	156,376	0	Jul 14 04:36 PM
Swisher Daniel N JR	Director	Jul 10 '25	Proposed Sale	71.08	2,200	156,376		Jul 10 12:21 PM

TV

Grupo Televisa SAB ADR

DBB

Invesco DB Base Metals Fund

CORT

Corcept Therapeutics Inc

Upgrade your FINVIZ experience